Therefore, despite the potential utility of small-molecule inhibitors or PROTACs in blocking BET protein function, it is currently unclear whether the inhibition or depletion of BRDT activity would be sufficient to impede ESCC tumor growth. The gene discussed is BRDT; the disease is esophageal squamous cell carcinoma.